Asporin, a class I small leucine-rich proteoglycan, regulates chondrogenesis, and inhibits TGFβ1-induced expression of matrix genes (Nakajima et al., 2007), acting as a critical regulator of joint diseases, including osteoarthritis (Coburn, 2005). This evidence concerns the gene ASPN and arthropathy.